Related references
Note: Only part of the references are listed.Muscle oxidative capacity during IL-6-dependent cancer cachexia
James P. White et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70
Sarah M. Senf et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics
M. Muscaritoli et al.
CLINICAL NUTRITION (2010)
Mitochondrial fission and remodelling contributes to muscle atrophy
Vanina Romanello et al.
EMBO JOURNAL (2010)
Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
James A. Carson et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2010)
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?
Fabio Penna et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice
Michelle L. Asp et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Control of Translation Initiation through Integration of Signals Generated by Hormones, Nutrients, and Exercise
Scot R. Kimball et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Overload-induced skeletal muscle extracellular matrix remodelling and myofibre growth in mice lacking IL-6
J. P. White et al.
ACTA PHYSIOLOGICA (2009)
Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
S. T. Russell et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
The Interaction of a High-Fat Diet and Regular Moderate Intensity Exercise on Intestinal Polyp Development in ApcMin/+ Mice
Kristen A. Baltgalvis et al.
CANCER PREVENTION RESEARCH (2009)
Autophagy Is Required to Maintain Muscle Mass
Eva Masiero et al.
CELL METABOLISM (2009)
Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury
James P. White et al.
JOURNAL OF APPLIED PHYSIOLOGY (2009)
Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc Min/+ mouse
Kristen A. Baltgalvis et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2009)
Interleukin-6 and cachexia in ApcMin/+ mice
Kristen A. Baltgalvis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin Deficiency
Junping Hu et al.
ENDOCRINOLOGY (2008)
Effect of exercise on biological pathways in ApcMin/+ mouse intestinal polyps
Kristen A. Baltgalvis et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions
David M. Thomson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals
Gerrit van Hall et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
Effect of branched-chain amino acids on muscle atrophy in cancer cachexia
Helen L. Eley et al.
BIOCHEMICAL JOURNAL (2007)
AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes
Kazuki Nakashima et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2007)
Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass
Robert A. Frost et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
AMP-activated protein kinase agonists increase mRNA content of the muscle-specific ubiquitin ligases MAFbx and MuRF1 in C2C12 cells
Brian J. Krawiec et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
IGF-1 is downregulated in experimental cancer cachexia
Paola Costelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR
David L. Williamson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
AMP-activated protein kinase signaling in metabolic regulation
Yun Chau Long et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Myofibrillar protein synthesis in myostatin-deficient mice
S Welle et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Prevention and treatment of cancer cachexia: New insights into an old problem
M Muscaritoli et al.
EUROPEAN JOURNAL OF CANCER (2006)
Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia
J Khal et al.
BRITISH JOURNAL OF CANCER (2005)
Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight
J Khal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Skeletal muscle mRNA for IGF-IEa, IGF-II, and IGF-I receptor is decreased in sedentary chronic hemodialysis patients
H Wang et al.
KIDNEY INTERNATIONAL (2005)
Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice
KA Mehl et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Autophagy in metazoans: Cell survival in the land of plenty
JJ Lum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway
E Latres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status
SWY Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte
AYM Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
SH Lecker et al.
FASEB JOURNAL (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis
S Horman et al.
CURRENT BIOLOGY (2002)
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
K Hara et al.
CELL (2002)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
Anticytokine treatment prevents the increase in the activity of ATP-ubiquitin- and Ca2+-dependent proteolytic systems in the muscle of tumour-bearing rats
P Costelli et al.
CYTOKINE (2002)
AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
DR Bolster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
